ClinConnect ClinConnect Logo
Search / Trial NCT06892626

Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy As Primary Treatment in Renal Stones 2-3 Cm

Launched by CAIRO UNIVERSITY · Mar 21, 2025

Trial Information

Current as of April 29, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • stone burden from 2- 3 cm, single or multiple stones and radio-opaque or radio-lucent stones.
  • Exclusion Criteria:
  • stone burden from 2- 3 cm, single or multiple stones and radio-opaque or radio-lucent stones.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported